BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8824371)

  • 1. Pelvic inflammatory disease and risk of ovarian cancer.
    Parazzini F; La Vecchia C; Negri E; Moroni S; dal Pino D; Fedele L
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):667-9. PubMed ID: 8824371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pelvic inflammatory disease and the risk of epithelial ovarian cancer.
    Risch HA; Howe GR
    Cancer Epidemiol Biomarkers Prev; 1995; 4(5):447-51. PubMed ID: 7549798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk.
    Parazzini F; Negri E; La Vecchia C; Luchini L; Mezzopane R
    Obstet Gynecol; 1993 Mar; 81(3):363-6. PubMed ID: 8437787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for ovarian cancer in central Italy.
    Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
    Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer.
    Chiaffarino F; Parazzini F; Decarli A; Franceschi S; Talamini R; Montella M; La Vecchia C
    Gynecol Oncol; 2005 May; 97(2):318-22. PubMed ID: 15863124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time since last birth and the risk of ovarian cancer.
    Chiaffarino F; Parazzini F; Negri E; Benzi G; Scarfone G; Franceschi S; La Vecchia C
    Gynecol Oncol; 2001 May; 81(2):233-6. PubMed ID: 11330955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors.
    Rasmussen CB; Faber MT; Jensen A; Høgdall E; Høgdall C; Blaakær J; Kjaer SK
    Cancer Causes Control; 2013 Jul; 24(7):1459-64. PubMed ID: 23615817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of pregnancy and the risk of epithelial ovarian cancer.
    Whiteman DC; Siskind V; Purdie DM; Green AC
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal douching as a risk factor for acute pelvic inflammatory disease.
    Scholes D; Daling JR; Stergachis A; Weiss NS; Wang SP; Grayston JT
    Obstet Gynecol; 1993 Apr; 81(4):601-6. PubMed ID: 8459976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breastfeeding and the risk of epithelial ovarian cancer in an Italian population.
    Chiaffarino F; Pelucchi C; Negri E; Parazzini F; Franceschi S; Talamini R; Montella M; Ramazzotti V; La Vecchia C
    Gynecol Oncol; 2005 Aug; 98(2):304-8. PubMed ID: 15975644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Older" age is a risk factor for pelvic inflammatory disease in intrauterine device users.
    Viberga I; Odlind V; Berglund L
    Acta Obstet Gynecol Scand; 2005 Dec; 84(12):1202-7. PubMed ID: 16305709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.
    Arslan AA; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Lukanova A; Afanasyeva Y; Lenner P; Krogh V; Muti P; Rinaldi S; Kaaks R; Berrino F; Hallmans G; Toniolo P
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1531-5. PubMed ID: 14693749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies.
    Pelucchi C; Galeone C; Talamini R; Bosetti C; Montella M; Negri E; Franceschi S; La Vecchia C
    Am J Obstet Gynecol; 2007 Jan; 196(1):83.e1-7. PubMed ID: 17240246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin and epithelial ovarian cancer.
    Akhmedkhanov A; Toniolo P; Zeleniuch-Jacquotte A; Kato I; Koenig KL; Shore RE
    Prev Med; 2001 Dec; 33(6):682-7. PubMed ID: 11716667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
    Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
    Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthropometry and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Ness RB; Allen GO
    Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
    Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of tubo-ovarian abscess in adolescents diagnosed with pelvic inflammatory disease in a pediatric emergency department.
    Mollen CJ; Pletcher JR; Bellah RD; Lavelle JM
    Pediatr Emerg Care; 2006 Sep; 22(9):621-5. PubMed ID: 16983244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.